(FY)Jun 30, 2024 | (FY)Jun 30, 2023 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | 4.44%-586.29K | -613.5K |
Payments to suppliers for goods and services | 4.44%-586.29K | ---613.5K |
Direct interest received | -44.06%6.51K | --11.64K |
Operating cash flow | 3.67%-579.78K | ---601.86K |
Investing cash flow | ||
Cash flow from continuing investing activities | 59.35%-979.18K | -2.41M |
Capital expenditure reported | 75.67%-595.58K | ---2.45M |
Net PPE purchase and sale | -1,087.10%-383.6K | --38.86K |
Cash from discontinued investing activities | ||
Investing cash flow | 59.35%-979.18K | ---2.41M |
Financing cash flow | ||
Cash flow from continuing financing activities | 295.27%2.23M | 564.47K |
Net common stock issuance | 295.27%2.23M | --564.47K |
Cash from discontinued financing activities | ||
Financing cash flow | 295.27%2.23M | --564.47K |
Net cash flow | ||
Beginning cash position | -79.98%612.45K | --3.06M |
Current changes in cash | 127.48%672.21K | ---2.45M |
End cash Position | 109.76%1.28M | --612.45K |
Free cash from | 49.00%-1.56M | ---3.06M |
Accounting Standards | US-GAAP | US-GAAP |
No Data